Myoglobin Protects Breast Cancer Cells Due to Its ROS and NO Scavenging Properties

被引:15
|
作者
Quinting, Theresa [1 ]
Heymann, Anna Katharina [1 ]
Bicker, Anne [2 ]
Nauth, Theresa [2 ]
Bernardini, Andre [1 ]
Hankeln, Thomas [2 ]
Fandrey, Joachim [1 ]
Schreiber, Timm [1 ,3 ,4 ]
机构
[1] Univ Duisburg Essen, Inst Physiol, Essen, Germany
[2] Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut Mol Genet & Genome Ana, Mainz, Germany
[3] Univ Witten Herdecke, Inst Physiol Pathophysiol & Toxicol, Witten, Germany
[4] Univ Witten Herdecke, Ctr Biomed Educ & Res, Witten, Germany
来源
FRONTIERS IN ENDOCRINOLOGY | 2021年 / 12卷
关键词
myoglobin; breast cancer; HIF; hypoxia; ROS; NO; tumor; INDUCIBLE FACTOR-I; HYDROGEN-PEROXIDE; NITRIC-OXIDE; ENDOGENOUS MYOGLOBIN; HYPOXIA; EXPRESSION; TUMOR; OXYGEN; HIF-1-ALPHA; NECROSIS;
D O I
10.3389/fendo.2021.732190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myoglobin (MB) is an oxygen-binding protein usually found in cardiac myocytes and skeletal muscle fibers. It may function as a temporary storage and transport protein for O-2 but could also have scavenging capacity for reactive oxygen and nitrogen species. In addition, MB has recently been identified as a hallmark in luminal breast cancer and was shown to be robustly induced under hypoxia. Cellular responses to hypoxia are regulated by the transcription factor hypoxia-inducible factor (HIF). For exploring the function of MB in breast cancer, we employed the human cell line MDA-MB-468. Cells were grown in monolayer or as 3D multicellular spheroids, which mimic the in vivo avascular tumor architecture and physiology with a heterogeneous cell population of proliferating cells in the rim and non-cycling or necrotic cells in the core region. This central necrosis was increased after MB knockdown, indicating a role for MB in hypoxic tumor regions. In addition, MB knockdown caused higher levels of HIF-1 alpha protein after treatment with NO, which also plays an important role in cancer cell survival. MB knockdown also led to higher reactive oxygen species (ROS) levels in the cells after treatment with H2O2. To further explore the role of MB in cell survival, we performed RNA-Seq after MB knockdown and NO treatment. 1029 differentially expressed genes (DEGs), including 45 potential HIF-1 target genes, were annotated in regulatory pathways that modulate cellular function and maintenance, cell death and survival, and carbohydrate metabolism. Of these target genes, TMEFF1, TREX2, GLUT-1, MKNK-1, and RAB8B were significantly altered. Consistently, a decreased expression of GLUT-1, MKNK-1, and RAB8B after MB knockdown was confirmed by qPCR. All three genes of interest are often up regulated in cancer and correlate with a poor clinical outcome. Thus, our data indicate that myoglobin might influence the survival of breast cancer cells, possibly due to its ROS and NO scavenging properties and could be a valuable target for cancer therapy.</p>
引用
收藏
页数:15
相关论文
共 50 条
  • [31] The Long-Term DEHP Exposure Confers Multidrug Resistance of Triple-Negative Breast Cancer Cells through ABC Transporters and Intracellular ROS
    Jadhao, Mahendra
    Tsai, Eing-Mei
    Yang, Ho-Chun
    Chen, Yih-Fung
    Liang, Shih-Shin
    Wang, Tsu-Nai
    Teng, Yen-Ni
    Huang, Hurng-Wern
    Wang, Li-Fang
    Chiu, Chien-Chih
    ANTIOXIDANTS, 2021, 10 (06)
  • [32] Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells
    Lāsma Ivanova
    Elīna Zandberga
    Karīna Siliņa
    Zane Kalniņa
    Artūrs Ābols
    Edgars Endzeliņš
    Ineta Vendina
    Nadezhda Romanchikova
    Alinta Hegmane
    Pēteris Trapencieris
    Jānis Eglītis
    Aija Linē
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 235 - 246
  • [33] Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells
    Ivanova, Lasma
    Zandberga, Elina
    Silina, Karina
    Kalnina, Zane
    Abols, Arturs
    Endzelins, Edgars
    Vendina, Ineta
    Romanchikova, Nadezhda
    Hegmane, Alinta
    Trapencieris, Peteris
    Eglitis, Janis
    Line, Aija
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (02) : 235 - 246
  • [34] Redox homeostasis protects mitochondria through accelerating ROS conversion to enhance hypoxia resistance in cancer cells
    Li, Pengying
    Zhang, Dongyang
    Shen, Lingxiao
    Dong, Kelei
    Wu, Meiling
    Ou, Zhouluo
    Shi, Dongyun
    SCIENTIFIC REPORTS, 2016, 6
  • [35] Dielectrophoretic properties distinguish responses to estrogen and fulvestrant in breast cancer cells
    Kikkeri, Kruthika
    Soltanian-Zadeh, Sepeedah
    Shajahan-Haq, Ayesha N.
    Jin, Lu
    Strobl, Jeannine
    Clarke, Robert
    Agah, Masoud
    SENSORS AND ACTUATORS B-CHEMICAL, 2018, 277 : 186 - 194
  • [36] Systemic platelet inhibition with localized chemotherapy by an injectable ROS-scavenging gel against postsurgical breast cancer recurrence and metastasis
    Gui, Jiajia
    Zhu, Yueting
    Chen, Xue
    Gong, Tao
    Zhang, Zhirong
    Yu, Ruilian
    Fu, Yao
    ACTA BIOMATERIALIA, 2024, 177 : 388 - 399
  • [37] Magnetic Nano-Particles: Properties, Synthesis and its Application in Treatment of Breast Cancer-A Critical Review
    Shobhana, N.
    Goudanavar, Prakash
    Mallamma, T.
    Akondi, Butchi Raju
    JOURNAL OF YOUNG PHARMACISTS, 2024, 16 (03) : 416 - 424
  • [38] Hemagglutinin protease secreted by V-cholerae induced apoptosis in breast cancer cells by ROS mediated intrinsic pathway and regresses tumor growth in mice model
    Ray, Tanusree
    Chakrabarti, Monoj Kumar
    Pal, Amit
    APOPTOSIS, 2016, 21 (02) : 143 - 154
  • [39] Disulfiram potentiates docetaxel cytotoxicity in breast cancer cells through enhanced ROS and autophagy
    K. Laxmi Swetha
    Swati Sharma
    Rajdeep Chowdhury
    Aniruddha Roy
    Pharmacological Reports, 2020, 72 : 1749 - 1765
  • [40] Cytotoxicity and mechanism of action of a new ROS-generating microsphere formulation for circumventing multidrug resistance in breast cancer cells
    Liu, Qun
    Shuhendler, Adam
    Cheng, Ji
    Rauth, Andrew Michael
    O'Brien, Peter
    Wu, Xiao Yu
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 121 (02) : 323 - 333